RecruitingNCT07130981
Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
Evaluation of Body Composition, Psychosocial Factors, and Drug-Related Problems in Relation to Clinical Progression in Cancer Patients Receiving Immune Checkpoint Inhibitors
Sponsor
Hacettepe University
Enrollment
200 participants
Start Date
Sep 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Aged 18 years or older
- Having undergone a CT scan (at the L3 level) prior to treatment
- No severe mental disorder and able to communicate effectively
- Provided written informed consent
Exclusion Criteria2
- Did not provide written informed consent
- Patients deemed unsuitable by the physician
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07130981
Related Trials
Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials
NCT073904353 locations
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
NCT0586228558 locations
Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)
NCT062190831 location
MR-BIO: A Study to Evaluate Changes in MR Imaging and Biological Parameters
NCT049032361 location
A Natural History Study of Metabolic Sizing in Health and Disease
NCT053987831 location